Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CanBas CoTSE:4575 +5.99%31 Market Cap is 円15,683.63 Mil as of Jul. 16, 2026. GuruFocus rates TSE:4575 with a GF Score™ of 31/100. Among 1,423 Biotechnology companies, CanBas Co ranks worse than 53.06% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). CanBas Co's share price for the quarter that ended in Dec. 2025 was 円803. CanBas Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 19.70 Mil. Therefore, CanBas Co's market cap for the quarter that ended in Dec. 2025 was 円15,821.51 Mil.
CanBas Co's quarterly market cap
declined
from Jun. 2025 (円23,545.09 Mil) to Sep. 2025 (円21,436.86 Mil) and
declined
from Sep. 2025 (円21,436.86 Mil) to Dec. 2025 (円15,821.51 Mil).
CanBas Co's annual market cap
declined
from Jun. 2023 (円20,165.85 Mil) to Jun. 2024 (円9,786.49 Mil) but then
increased
from Jun. 2024 (円9,786.49 Mil) to Jun. 2025 (円23,545.09 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. CanBas Co's Enterprise Value for Today is 円13,918.33 Mil.
CanBas Co (TSE:4575) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
CanBas Co Market Cap Related Terms
CanBas Co Market Cap Historical Data
* Premium members only.
The historical data trend for CanBas Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4575 vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, CanBas Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CanBas Co Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CanBas Co's Market Cap distribution charts can be found below:
* The bar in red indicates where CanBas Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
CanBas Co's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CanBas Co (TSE:4575) has a Market Cap of 円15,683.63 Mil as of Jul. 16, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on CanBas Co and its competitors. According to the industry distribution chart, CanBas Co ranks #755 out of 1423 companies in the Biotechnology industry, placing it in the top 53.1%.
Is CanBas Co's Market Cap too high?
CanBas Co's current Market Cap is 円15,683.63 Mil. Based on the distribution chart, CanBas Co ranks #755 out of 1423 companies in the Biotechnology industry, which is below the industry midpoint. Overall, CanBas Co has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does CanBas Co's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CanBas Co ranks #755 out of 1423 companies for Market Cap. This places CanBas Co in the lower half of its industry. The industry median Market Cap is 117.38. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 117.38, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on CanBas Co and its competitors. For the Biotechnology industry, the median Market Cap is 117.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CanBas Co's current Market Cap is 円15,683.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CanBas Co stock overvalued right now?
CanBas Co (TSE:4575) has a current Market Cap of 円15,683.63 Mil. The current Market Cap is 円15,683.63 Mil. CanBas Co's overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For CanBas Co (TSE:4575), the current Market Cap is 円15,683.63 Mil as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CanBas Co Ltd focuses on the discovery and development of novel oncology drugs targeting the cell cycle. Its product, CBP501 the anticancer drug candidate is a modified synthetic peptide which enhances the efficacy of cisplatin without adding toxicity.
31GF Score
Get the complete analysis for TSE:4575
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4575 has been successfully added to your 
